Cryoport (CYRX) Competitors $6.22 -0.41 (-6.18%) Closing price 04:00 PM EasternExtended Trading$6.20 -0.01 (-0.24%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CYRX vs. VIR, SNDX, ARVN, ANIP, DAWN, ADPT, RCUS, CALT, SYRE, and SPRYShould you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Vir Biotechnology (VIR), Syndax Pharmaceuticals (SNDX), Arvinas (ARVN), ANI Pharmaceuticals (ANIP), Day One Biopharmaceuticals (DAWN), Adaptive Biotechnologies (ADPT), Arcus Biosciences (RCUS), Calliditas Therapeutics AB (publ) (CALT), Spyre Therapeutics (SYRE), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical products" industry. Cryoport vs. Vir Biotechnology Syndax Pharmaceuticals Arvinas ANI Pharmaceuticals Day One Biopharmaceuticals Adaptive Biotechnologies Arcus Biosciences Calliditas Therapeutics AB (publ) Spyre Therapeutics ARS Pharmaceuticals Vir Biotechnology (NASDAQ:VIR) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Does the media favor VIR or CYRX? In the previous week, Vir Biotechnology had 6 more articles in the media than Cryoport. MarketBeat recorded 9 mentions for Vir Biotechnology and 3 mentions for Cryoport. Vir Biotechnology's average media sentiment score of 0.46 beat Cryoport's score of 0.45 indicating that Vir Biotechnology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vir Biotechnology 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cryoport 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, VIR or CYRX? Vir Biotechnology has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Which has stronger valuation and earnings, VIR or CYRX? Cryoport has higher revenue and earnings than Vir Biotechnology. Vir Biotechnology is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVir Biotechnology$86.18M15.29-$615.06M-$3.92-2.44Cryoport$233.26M1.32-$99.59M-$3.38-1.84 Is VIR or CYRX more profitable? Cryoport has a net margin of -70.08% compared to Vir Biotechnology's net margin of -678.40%. Cryoport's return on equity of -13.35% beat Vir Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Vir Biotechnology-678.40% -36.71% -31.00% Cryoport -70.08%-13.35%-6.43% Do institutionals & insiders have more ownership in VIR or CYRX? 65.3% of Vir Biotechnology shares are owned by institutional investors. Comparatively, 92.9% of Cryoport shares are owned by institutional investors. 15.6% of Vir Biotechnology shares are owned by insiders. Comparatively, 10.1% of Cryoport shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor VIR or CYRX? Cryoport received 190 more outperform votes than Vir Biotechnology when rated by MarketBeat users. Likewise, 65.15% of users gave Cryoport an outperform vote while only 54.64% of users gave Vir Biotechnology an outperform vote. CompanyUnderperformOutperformVir BiotechnologyOutperform Votes5354.64% Underperform Votes4445.36% CryoportOutperform Votes24365.15% Underperform Votes13034.85% Do analysts rate VIR or CYRX? Vir Biotechnology presently has a consensus target price of $34.83, indicating a potential upside of 263.98%. Cryoport has a consensus target price of $12.29, indicating a potential upside of 97.52%. Given Vir Biotechnology's stronger consensus rating and higher probable upside, analysts clearly believe Vir Biotechnology is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vir Biotechnology 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Cryoport 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryCryoport beats Vir Biotechnology on 11 of the 18 factors compared between the two stocks. Get Cryoport News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoportPharmaceutical IndustryTransportation SectorNASDAQ ExchangeMarket Cap$307.46M$7.05B$305.02B$8.94BDividend YieldN/A2.87%4.25%3.85%P/E Ratio-1.846.0913.2718.84Price / Sales1.32314.1057.5276.68Price / Cash17.6167.8312.4737.47Price / Book0.666.752.034.64Net Income-$99.59M$138.11M$552.84M$245.69M7 Day Performance-7.58%-1.99%-2.35%-2.59%1 Month Performance-23.77%-1.51%-2.92%-2.30%1 Year Performance-61.37%-3.20%2.59%13.71% Cryoport Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoport2.6151 of 5 stars$6.22-6.2%$12.29+97.5%-58.3%$307.46M$233.26M-1.841,170VIRVir Biotechnology3.337 of 5 stars$9.65+0.7%$34.83+261.0%-4.2%$1.33B$86.18M-2.46580Insider TradeSNDXSyndax Pharmaceuticals3.6711 of 5 stars$14.92-1.1%$36.20+142.6%-30.1%$1.27BN/A-4.11110ARVNArvinas3.1093 of 5 stars$18.31+3.6%$60.00+227.7%-63.7%$1.26B$78.50M-3.92420Gap UpANIPANI Pharmaceuticals4.4126 of 5 stars$58.92-0.5%$77.71+31.9%+2.3%$1.24B$486.82M-107.13600DAWNDay One Biopharmaceuticals1.993 of 5 stars$12.26+0.4%$35.71+191.3%-17.9%$1.24B$101.95M-11.9060Upcoming EarningsADPTAdaptive Biotechnologies3.6903 of 5 stars$8.33-2.2%$8.30-0.4%+116.4%$1.23B$170.28M-6.22790Analyst ForecastInsider TradeRCUSArcus Biosciences2.7933 of 5 stars$13.05+2.8%$32.67+150.3%-35.2%$1.19B$117M-4.14500Analyst ForecastAnalyst RevisionNews CoverageGap UpCALTCalliditas Therapeutics AB (publ)0.1187 of 5 stars$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180SYRESpyre Therapeutics2.1054 of 5 stars$22.92+1.1%$54.83+139.2%+2.1%$1.18B$890,000.00-3.07100Analyst UpgradeNews CoverageSPRYARS Pharmaceuticals2.8846 of 5 stars$12.02+0.8%$28.80+139.6%+56.6%$1.17B$30,000.00-23.5790News CoverageGap Up Related Companies and Tools Related Companies Vir Biotechnology Competitors Syndax Pharmaceuticals Competitors Arvinas Competitors ANI Pharmaceuticals Competitors Day One Biopharmaceuticals Competitors Adaptive Biotechnologies Competitors Arcus Biosciences Competitors Calliditas Therapeutics AB (publ) Competitors Spyre Therapeutics Competitors ARS Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CYRX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryoport With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts